Skin Cancer Research Today is a free monthly online journal that collates and summarizes the latest research about Skin Cancer, including details on identification, causes, prevention, treatment.

Volume 3 (2006), Issue 1 (January)

1. EZH2 expression is associated with high proliferation rate and aggressive tumor subgroups in cutaneous melanoma and cancers of the endometrium, prostate, and breast.
   J Clin Oncol, 24(2): 268-73. [Abstract] [Full-text]
2. Array-based comparative genomic hybridization analysis reveals recurrent chromosomal alterations and prognostic parameters in primary cutaneous large B-cell lymphoma.
   J Clin Oncol, 24(2): 296-305. [Abstract] [Full-text]
3. Multi-gene epigenetic silencing of tumor suppressor genes in T-cell lymphoma cells; delayed expression of the p16 protein upon reversal of the silencing.
   Leuk Res, 30(3): 303-12. [Abstract] [Full-text]
4. A new dendritic cell vaccine generated with interleukin-3 and interferon-beta induces CD8+ T cell responses against NA17-A2 tumor peptide in melanoma patients.
   Cancer Immunol Immunother, 55(4): 469-74. [Abstract] [Full-text]
5. Melanoma-specific tumor-infiltrating lymphocytes but not circulating melanoma-specific T cells may predict survival in resected advanced-stage melanoma patients.
   Cancer Immunol Immunother, 55(4): 451-8. [Abstract] [Full-text]
6. Development of an allogeneic whole-cell tumor vaccine expressing xenogeneic gp100 and its implementation in a phase II clinical trial in canine patients with malignant melanoma.
   Cancer Immunol Immunother, 55(4): 433-42. [Abstract] [Full-text]
7. Hair follicle defects and squamous cell carcinoma formation in Smad4 conditional knockout mouse skin.
   Oncogene, 25(2): 207-17. [Abstract] [Full-text]
8. Influence of the cytoplasmic domain of E-cadherin on endogenous N-cadherin expression in malignant melanoma.
   Oncogene, 25(2): 248-59. [Abstract] [Full-text]
9. Keratinocyte apoptosis in epidermal development and disease.
   J Invest Dermatol, 126(2): 243-57. [Abstract] [Full-text]
10. Porphyrin formation in actinic keratosis and basal cell carcinoma after topical application of methyl 5-aminolevulinate.
    J Invest Dermatol, 126(2): 265-71. [Abstract] [Full-text]
11. Epigenetic inactivation of tumor suppressor genes in serum of patients with cutaneous melanoma.
    J Invest Dermatol, 126(2): 422-31. [Abstract] [Full-text]
12. Germline CDKN2A mutations among Greek patients with early-onset and multiple primary cutaneous melanoma.
    J Invest Dermatol, 126(2): 399-401. [Abstract] [Full-text]
13. Heterogeneity of T-cell clones infiltrating primary malignant melanomas.
    J Invest Dermatol, 126(2): 393-8. [Abstract] [Full-text]
14. Differential induction of connexins 26 and 30 in skin tumors and their adjacent epidermis.
    J Histochem Cytochem, 54(2): 171-82. [Abstract] [Full-text]
15. The in vivo expansion rate of properly stimulated transferred CD8+ T cells exceeds that of an aggressively growing mouse tumor.
    Cancer Res, 66(2): 1132-8. [Abstract] [Full-text]
16. Oncogenic BRAF is required for tumor growth and maintenance in melanoma models.
    Cancer Res, 66(2): 999-1006. [Abstract] [Full-text]
17. Protein kinase C delta overexpressing transgenic mice are resistant to chemically but not to UV radiation-induced development of squamous cell carcinomas: a possible link to specific cytokines and cyclooxygenase-2.
    Cancer Res, 66(2): 713-22. [Abstract] [Full-text]
18. Thymosin beta4 is a determinant of the transformed phenotype and invasiveness of S-adenosylmethionine decarboxylase-transfected fibroblasts.
    Cancer Res, 66(2): 701-12. [Abstract] [Full-text]
19. Sun exposure and risk of melanoma.
    Arch Dis Child, 91(2): 131-8. [Abstract] [Full-text]
20. Cartilage hair hypoplasia and multiple basal cell carcinomas.
    J Am Acad Dermatol, 54(2): S8-10. [Abstract] [Full-text]
21. Tumour lymphangiogenesis is a possible predictor of sentinel lymph node status in cutaneous melanoma: a case-control study.
    J Clin Pathol, 59(2): 166-73. [Abstract] [Full-text]
22. Clinicopathologic features of skin cancer in organ transplant recipients: a retrospective case-control series.
    J Am Acad Dermatol, 54(2): 290-300. [Abstract] [Full-text]
23. Low plasma coenzyme Q10 levels as an independent prognostic factor for melanoma progression.
    J Am Acad Dermatol, 54(2): 234-41. [Abstract] [Full-text]
24. Dermatomyositis associated with malignant melanoma--a marker of poor prognosis?
    J Am Acad Dermatol, 54(2): 221-6. [Abstract] [Full-text]
25. Cutaneous malignancy and human immunodeficiency virus disease.
    J Am Acad Dermatol, 54(2): 189-206; quiz 207-10. [Abstract] [Full-text]

© 2004-2008 Skin Cancer Research Today. All Rights Reserved.